Company
Quell Therapeutics
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Quell Therapeutics was founded with the aim of developing engineered T regulatory (Treg) cell therapies. Tregs are a subset of T cells with the potential to downregulate the immune system.
Loading relationship preview